Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model (Q44550012)

4 December 2017

title

Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model (English)

1 reference

4 December 2017

1 reference

Melvin E Andersen

3

0 references

Harvey J Clewell

series ordinal

4

object named as

Harvey J Clewell

1 reference

4 December 2017

Anne E Loccisano

1

1 reference

4 December 2017

Jerry L Campbell

series ordinal

2

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

Regulatory Toxicology and Pharmacology

4 December 2017

published in

1 reference

4 December 2017

volume

59

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

157-175

1 reference

Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Disposition of perfluorinated acid isomers in Sprague-Dawley rats; part 1: single dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Physiological parameter values for physiologically based pharmacokinetic models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Physiological parameters in laboratory animals and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARα and CAR/PXR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Analysis of respiratory exchange of methanol in the lung of the monkey using a physiological model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Normal distribution of cardiac output in the unanesthetized, restrined rhesus monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

The C8 health project: design, methods, and participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Perfluorinated compounds--exposure assessment for the general population in Western countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Binding of perfluorooctanoic acid to rat and human plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Elimination and toxicity of perfluorooctanoic acid during subchronic administration in the Wistar rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

One-year follow-up of perfluorinated compounds in plasma of German residents from Arnsberg formerly exposed to PFOA-contaminated drinking water

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Binding of perfluorinated fatty acids to serum proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

The toxicology of perfluorooctanoate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Sex hormone-regulated renal transport of perfluorooctanoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Tissue distribution and hepatic subcellular distribution of perfluorooctanoic acid at low dose are different from those at high dose in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Lack of evidence for perfluorodecanoyl- or perfluorooctanoyl-coenzyme A formation in male and female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Perfluoroalkyl acids: a review of monitoring and toxicological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

The developmental toxicity of perfluoroalkyl acids and their derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Interactions of fluorochemicals with rat liver fatty acid-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Human organic anion transporter hOAT4 is a transporter of perfluorooctanoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Metabolic Handling of perfluorooctanoic acid in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Historic dietary exposure to perfluorooctane sulfonate, perfluorinated carboxylates, and fluorotelomer unsaturated carboxylates from the consumption of store-bought and restaurant foods for the Canadian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

A methodology for estimating human exposure to perfluorooctanoic acid (PFOA): a retrospective exposure assessment of a community (1951-2003).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Sources, fate and transport of perfluorocarboxylates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

28-Day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: does the route of administration play a pivotal role in

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Pharmacokinetic modeling of perfluorooctanoic acid during gestation and lactation in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Perfluorinated surfactants in surface and drinking waters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Predictors of PFOA levels in a community surrounding a chemical plant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Perfluorinated compounds in house dust from Ohio and North Carolina, USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Time dependencies in perfluorooctylacids disposition in rat and monkeys: a kinetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Tracking the pathways of human exposure to perfluorocarboxylates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Exposure assessment and risk characterization for perfluorooctanoate in selected consumer articles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Assessment and management of the first German case of a contamination with perfluorinated compounds (PFC) in the Region Sauerland, North Rhine-Westphalia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Organic anion transporting polypeptide (Oatp) 1a1-mediated perfluorooctanoate transport and evidence for a renal reabsorption mechanism of Oatp1a1 in renal elimination of perfluorocarboxylates in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

Effects of peroxisome proliferators on the thymus and spleen of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.12.004

10.1016/J.YRTPH.2010.12.004

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference